T Cells Responsive to Myelin Basic Protein in Patients with Multiple Sclerosis
- 9 February 1990
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 247 (4943) , 718-721
- https://doi.org/10.1126/science.1689076
Abstract
Gene mutation in vivo in human T lymphocytes appears to occur preferentially in dividing cells. Individuals with multiple sclerosis (MS) are assumed to have one or more populations of diving T cells that are being stimulated by autoantigens. Mutant T cell clones from MS patients were isolated and tested for reactivity to myelin basic protein, an antigen that is thought to participate in the induction of the disease. The hypoxanthine guanine phosphoribosyltransferase (hprt) clonal assay was used to determine mutant frequency values in MS patients with chronic progressive disease. Eleven of 258 thioguanine-resistant (hprt-) T cell clones from five of the six MS patients who were tested proliferated in response to human myelin basic protein without prior in vitro exposure to this antigen. No wild-type clones from these patients, nor any hprt- or wild-type clones from three healthy individuals responded to myelin basic protein. Thus, T cell clones that react with myelin basic protein can be isolated from the peripheral blood of MS patients.Keywords
This publication has 21 references indexed in Scilit:
- T Cell Receptors in Murine Autoimmune DiseasesAnnual Review of Immunology, 1989
- Longitudinal study of the in vivo hprt mutant frequency in human T‐lymphocytes as determined by a cell cloning assayEnvironmental and Molecular Mutagenesis, 1989
- Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different.The Journal of Experimental Medicine, 1989
- Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyCell, 1988
- Molecular analyses of in vivo hypoxanthine‐guanine phosphoribosyltransferase mutations in human T‐lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T‐lymphocytes in vivoEnvironmental Mutagenesis, 1988
- Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytesMutation Research Letters, 1986
- Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytesNature, 1985
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985
- SCE, X-radiation sensitivity and mutation rate in multiple sclerosisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1983
- Multiple SclerosisNew England Journal of Medicine, 1982